Market capitalization | $957.77m |
Enterprise Value | $953.43m |
PER (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 6.94 |
P/S ratio (TTM) P/S ratio | 6.98 |
P/B ratio (TTM) P/B ratio | 2.85 |
Sales growth (TTM) Sales growth | -15.89% |
Turnover (TTM) Turnover | $137.30m |
As a free StocksGuide basic user, you can view the scores for all 6,954 shares worldwide.
9 Analysts have issued a BioLife Solutions, Inc. forecast:
9 Analysts have issued a BioLife Solutions, Inc. forecast:
Mar '24 | |
Current assets | 112 112 |
Fixed assets | 290 290 |
Total assets | 402 402 |
Mar '24 | |
Equity | 333 333 |
Debt capital | 68 68 |
Total capital | 402 402 |
Figures in millions USD.
If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.
BioLife Solutions, Inc. engages in the development, manufacture, and marketing of biopreservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; and custom product formulation and custom packaging services. The company was founded by Boris Rubinsky in 1998 and it is headquartered in Bothell, WA.
Head office | United States |
CEO | Roderick Greef |
Employees | 414 |
Founded | 1987 |
Website | www.biolifesolutions.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.